Latest stories on VNRX
VolitionRx Announces Pricing of $4.6 Million Public Offering
PR Newswire58 · neutralgeneral
VolitionRx Announces Pricing of $4.6 Million Public Offering | VNRX Stock News
StockTitan53 · neutralgeneral
VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring
PR Newswire58 · neutralproduct/pr
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
PR Newswire67 · bullishproduct/pr
VolitionRx Limited (VNRX): 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts
Yahoo Top86 · bullishanalyst
VolitionRx Secures Waiver on Convertible Note Covenant Breach
TipRanks58 · neutralgeneral
VolitionRX Earnings Call Balances Breakthroughs and Risks
TipRanks53 · neutralearnings
VolitionRx anticipates first DETECSEPS patient in September as Q1 revenue rises to about $1M
Seeking Alpha58 · neutralearnings
VolitionRx Limited (VNRX) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
VolitionRX GAAP EPS of -$0.97 misses by $0.26, revenue of $0.99M beats by $0.46M
Seeking Alpha33 · bearishearnings
VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update
PR Newswire53 · neutralearnings
VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update
PR Newswire50 · neutralearnings